Premium
Genomewide linkage study of modifiers of LRRK2 ‐related Parkinson's disease
Author(s) -
Latourelle Jeanne C.,
Hendricks Audrey E.,
Pankratz Nathan,
Wilk Jemma B.,
Halter Cheryl,
Nichols William C.,
Gusella James F.,
Destefano Anita L.,
Myers Richard H.,
Foroud Tatiana
Publication year - 2011
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.23781
Subject(s) - lrrk2 , penetrance , genetics , single nucleotide polymorphism , biology , genetic linkage , odds ratio , genotyping , leucine rich repeat , genotype , mutation , medicine , gene , phenotype
Mutations in the leucine‐rich repeat kinase 2 gene, located at 12q12, are the most common known genetic causes of Parkinson's disease. Studies of leucine‐rich repeat kinase 2 mutation carriers have shown incomplete and age‐dependent penetrance, and previous studies have suggested that inherited susceptibility factors may modify the penetrance of leucine‐rich repeat kinase 2 mutations. Genomewide linkage to age of onset of leucine‐rich repeat kinase 2–related Parkinson's disease was evaluated in a sample of 113 leucine‐rich repeat kinase 2 mutation carriers from 64 families using single‐nucleotide polymorphism data from the Illumina HumanCNV370 genotyping array. Association between onset age and single‐nucleotide polymorphisms under suggestive linkage peaks was also evaluated. The top logarithmic odds score for onset age (logarithmic odds score = 2.43) was in the chromosome 1q32.1 region. Moderate linkage to onset was also identified at 16q12.1 (logarithmic odds score = 1.58). Examination of single‐nucleotide polymorphism association to Parkinson's disease onset under the linkage peaks revealed no statistically significant single‐nucleotide polymorphism associations. The 2 novel genomic regions identified may harbor modifiers of leucine‐rich repeat kinase 2–related Parkinson's disease onset age or penetrance, and further study of these regions may provide important insight into leucine‐rich repeat kinase 2–related Parkinson's disease. © 2011 Movement Disorder Society